genOway S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALGEN.PA research report →
About the company
genOway S. A. is a global biotechnology enterprise that specializes in the creation, production, commercialization, and distribution of custom genetically engineered mouse, rat, and cell line models.
- CEO
- Alexandre Fraichard
- IPO
- 2007
- Employees
- 124
- HQ
- Lyon, FR
Price Chart
- Market Cap
- $21.34M
- P/E
- 30.19
- P/S
- 1.02
- P/B
- 1.17
- EV/EBITDA
- 6.66
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 7.32%
- Net Margin
- 4.43%
- ROE
- 4.28%
- ROIC
- 0.00%
- Revenue
- $20.96M · -5.00%
- Net Income
- $928.00K · -49.32%
- EPS
- $0.07 · -60.79%
- Op Income
- $669.36K
- FCF YoY
- -512.54%
- 52W High
- $3.42
- 52W Low
- $2.10
- 50D MA
- $2.43
- 200D MA
- $2.54
- Beta
- 0.37
- Avg Volume
- 6.45K
Get TickerSpark's AI analysis on ALGEN.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALGEN.PA coverage
Recent articles, reports, and earnings notes.
No research on ALGEN.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALGEN.PA report →Similar companies
Peers in the same neighborhood.